CHOP-c-JUN complex plays a critical role in liver proteotoxicity induced by mutant Z alpha-1 antitrypsin.
Sergio AttanasioiD, Gwladys GernouxiD, Rosa FerrieroiD, Rossella De CegliiD, Annamaria CarissimoiD, Edoardo NuscoiD, Severo CampioneiD, Jeffrey H. TeckmaniD, Christian MuelleriD, Pasquale PiccoloiD, Nicola Brunetti‐PierriiD
Abstract
Alpha-1 antitrypsin (AAT) deficiency is a common genetic disorder with lung and liver involvement. Most patients carry the Z allele in SERPINA1 that encodes a mutant AAT (ATZ) forming hepatotoxic polymers. We found CHOP upregulation and activation in both mouse (PiZ) and human livers expressing ATZ. Compared to controls, juvenile PiZ/Chop-/- mice showed reduction in hepatic ATZ and transcriptional response to endoplasmic reticulum stress, as consequence of CHOP-mediated increase of SERPINA1 transcription. CHOP was found to upregulate SERPINA1 though binding with c-JUN on SERPINA1 regulatory elements, thus aggravating hepatic accumulation of ATZ. Increased CHOP levels were detected in diseased livers of children homozygous for the Z allele. Compared to adults, AAT deficiency in infants has different severity and prognosis. Based on our findings, CHOP-c-JUN complex upregulates SERPINA1 transcription and play an important role in the hepatic disease pathogenesis by increasing the burden of proteotoxic ATZ, particularly in the pediatric population.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SAHA increases chaperone expression and reduces Z-alpha-1-antitrypsin polymers in a patient specific iPSC-based liver model for alpha-1-antitrypsin deficiency
Nina Graffmann, Rabea Hokamp, … James Adjaye·Stem Cell Research & TherapyPeer-reviewed·Oct 27, 2026
- Small molecule screen employing patient-derived iPS hepatocytes identifies LRRK2 as a novel therapeutic target for Alpha1 Antitrypsin Deficiency
D. Kent, S. S. Ng, … S. T. Rashid·bioRxiv·Sep 17, 2021
- Both terminal misfolding and polymerisation contribute to disease-relevant phenotypic changes in cell models of alpha-1-antitrypsin deficiency-associated liver disease
Panayiota Stylianou, Kish R. Adoni, … Bibek Gooptu·bioRxiv·Sep 30, 2025
- Z-AAT impairs organelle homeostasis and reduces adaptive response to lipids in alpha-1 antitrypsin deficiency models
Sara Gil-Martín, Nerea Matamala, … Beatriz Martínez–Delgado·bioRxiv·Aug 17, 2026
- Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation
Nina Heyer‐Chauhan, Riccardo Ronzoni, … David A. Lomas·Bioscience ReportsPeer-reviewed·Oct 29, 2026
- Novel Transgenic Humanized Alpha-1 Antitrypsin Deficiency Mouse Model on Murine SERPINA1 Null Background
Regina A. Oshins, Alek M. Aranyos, … Nazli Khodayari·bioRxiv·Oct 11, 2024